telbivudine has been researched along with Muscle Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (12.50) | 29.6817 |
| 2010's | 13 (81.25) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Lin, P; Wu, W; Yan, C; Yu, W; Zhao, D | 1 |
| Cheng, Z; Song, S; Zhu, D; Zhu, X; Zou, S | 1 |
| Ahn, SH; Han, KH; Kim, EH; Kim, SM; Lee, KH; Park, H | 1 |
| Jang, JH; Kim, BJ; Lee, SW | 1 |
| Hu, P; Huang, XY; Jin, JL; Lu, JH; Luo, SS; Weng, XH; Zhang, JM | 1 |
| Fung, J; Lai, CL; Seto, WK; Yuen, MF | 1 |
| Jin, S; Lv, H; Wang, Z; Xu, H; Yuan, Y; Zhang, W; Zheng, L | 1 |
| Akarca, US; Bademkiran, F; Duman, S; Ersoz, G; Gunsar, F; Karasu, Z; Kose, T; Ozutemiz, O; Sozbilen, M; Turan, I; Yapali, S | 1 |
| Ambang, T; Goh, KJ; Ong, S; Tan, JS; Wong, KT | 1 |
| Fleischer, RD; Lok, AS | 1 |
| But, DY; Fung, J; Lai, CL; Yuen, MF | 1 |
| Ay, L; Finsterer, J | 1 |
| Dang, S; Gao, N; Jia, X; Zhang, X | 1 |
| Jiang, XQ; Tian, DY; Zou, XJ | 1 |
| Cai, H; Da, Y; Jia, J; Lu, Y; Wang, M; Wu, L | 1 |
| ButÃ, MA | 1 |
5 review(s) available for telbivudine and Muscle Disorders
| Article | Year |
|---|---|
Lactic acidosis during telbivudine treatment for HBV: a case report and literature review.
Topics: Acidosis, Lactic; Adult; Antiviral Agents; Hepatitis B, Chronic; Humans; Male; Mitochondrial Diseases; Muscular Diseases; Telbivudine; Thymidine | 2013 |
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.
Topics: Acidosis, Lactic; Adenine; Administration, Oral; Antiviral Agents; Arabinofuranosyluracil; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hepatitis B, Chronic; Humans; Kidney Diseases; Male; Muscular Diseases; Nervous System Diseases; Nucleosides; Nucleotides; Organophosphonates; Pharmacovigilance; Pregnancy; Telbivudine; Tenofovir; Thymidine | 2014 |
Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B.
Topics: Animals; Antiviral Agents; Arabinofuranosyluracil; Creatine Kinase; Drug Discovery; Early Termination of Clinical Trials; Hepatitis B, Chronic; Humans; Lamivudine; Mitochondrial Myopathies; Muscular Diseases; Nervous System Diseases; Nucleosides; Nucleotides; Pyrimidinones; Republic of Korea; Telbivudine; Thymidine | 2009 |
Safety evaluation of telbivudine.
Topics: Adult; Antiviral Agents; Biomarkers; Creatine Kinase; Double-Blind Method; Drug Resistance, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Humans; Isoenzymes; Male; Multicenter Studies as Topic; Muscular Diseases; Nucleosides; Peripheral Nervous System Diseases; Predictive Value of Tests; Pregnancy; Pregnancy Complications, Infectious; Pyrimidinones; Randomized Controlled Trials as Topic; Telbivudine; Thymidine | 2010 |
[Telbivudine in the treatment of the chronic B hepatitis].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Biomarkers, Pharmacological; Biotransformation; Clinical Trials, Phase III as Topic; Drug Resistance, Viral; Female; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Humans; Lamivudine; Male; Middle Aged; Muscular Diseases; Nucleosides; Phosphorylation; Prodrugs; Pyrimidinones; Randomized Controlled Trials as Topic; Telbivudine; Thymidine; Virus Replication | 2008 |
11 other study(ies) available for telbivudine and Muscle Disorders
| Article | Year |
|---|---|
Insights into the mechanisms of telbivudine-induced myopathy associated with mitochondrial dysfunction.
Topics: Animals; DNA, Mitochondrial; Mice; Mice, Inbred C57BL; Mitochondria; Muscular Diseases; Telbivudine | 2023 |
Telbivudine-Induced Myopathy Incidentally Detected by FDG PET/CT Imaging in a Patient With History of Hepatocellular Carcinoma.
Topics: Aged; Carcinoma, Hepatocellular; Fluorodeoxyglucose F18; Humans; Incidental Findings; Liver Neoplasms; Male; Muscular Diseases; Positron Emission Tomography Computed Tomography; Telbivudine | 2019 |
Two cases of telbivudine-induced myopathy in siblings with chronic hepatitis B.
Topics: Adult; Antiviral Agents; Creatine Kinase; Electromyography; Hepatitis B, Chronic; Humans; Male; Muscle, Skeletal; Muscular Diseases; Siblings; Telbivudine; Thymidine | 2013 |
Dysphagia could be the first presenting symptom of telbivudine-induced myopathy.
Topics: Aged; Antiviral Agents; Deglutition Disorders; Female; Humans; Muscular Diseases; Telbivudine; Thymidine | 2013 |
Lamivudine/telbivudine-associated neuromyopathy: neurogenic damage, mitochondrial dysfunction and mitochondrial DNA depletion.
Topics: Adult; Aged, 80 and over; Antiviral Agents; Biopsy; DNA, Mitochondrial; Female; Hepatitis B; Humans; Lamivudine; Male; Microscopy, Electron; Middle Aged; Mitochondria, Muscle; Muscle, Skeletal; Muscular Diseases; Peripheral Nerves; Peripheral Nervous System Diseases; Predictive Value of Tests; Real-Time Polymerase Chain Reaction; Retrospective Studies; Telbivudine; Thymidine; Young Adult | 2014 |
Telbivudine in liver transplant recipients: Renal protection does not overcome the risk of polyneuropathy and myopathy.
Topics: Aged; Antiviral Agents; Diabetes Mellitus; Drug Substitution; End Stage Liver Disease; Female; Glomerular Filtration Rate; Hepatitis B; Humans; Incidence; Kaplan-Meier Estimate; Kidney; Lamivudine; Liver Transplantation; Male; Middle Aged; Muscular Diseases; Polyneuropathies; Proportional Hazards Models; Prospective Studies; Recovery of Function; Recurrence; Renal Insufficiency, Chronic; Risk Factors; Telbivudine; Thymidine; Time Factors; Treatment Outcome; Turkey | 2015 |
Clinicopathological Features of Telbivudine-Associated Myopathy.
Topics: Aged; Female; Humans; Male; Middle Aged; Muscular Diseases; Telbivudine; Thymidine | 2016 |
Myotoxicity of telbivudine in pre-existing muscle damage.
Topics: Adult; Antiviral Agents; Creatine Kinase; Hepatitis B; Humans; Male; Muscle, Skeletal; Muscular Diseases; Nucleosides; Pyrimidinones; Telbivudine; Thymidine | 2010 |
Rhabdomyolysis in a 48-year-old man with hepatitis B-induced cirrhosis.
Topics: Acute Kidney Injury; Antiviral Agents; Fatal Outcome; Fibrosis; Hepatitis B; Humans; Male; Middle Aged; Muscular Diseases; Nucleosides; Pyrimidinones; Rhabdomyolysis; Telbivudine; Thymidine; Treatment Outcome | 2011 |
Clinical features and risk factors of creatine kinase elevations and myopathy associated with telbivudine.
Topics: Adolescent; Adult; Age Distribution; Aged; Antiviral Agents; Creatine Kinase; Female; Hepatitis B, Chronic; Humans; Incidence; Male; Middle Aged; Muscular Diseases; Nucleosides; Pyrimidinones; Risk Factors; Sex Distribution; Telbivudine; Thymidine; Young Adult | 2011 |
Telbivudine myopathy in a patient with chronic hepatitis B.
Topics: Adult; Antiviral Agents; Hepatitis B, Chronic; Humans; Male; Muscular Diseases; Telbivudine; Thymidine | 2012 |